Product Program year 2025 Source: CMS Open Payments

Freestyle Copilot

Device Diabetes Care

PDI 00357599000172

Open in the dashboard

General payments

$16,278

122 payments

Research payments

$0

0 payments

Through program year 2025, $16,278 in general payments and $0 in research payments were reported against Freestyle Copilot (Diabetes Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $6,159 48
2024 General $9,071 62
2023 General $1,011 10
2022 General $37 2

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $16,278 122 payments
Top recipients General payments · program year 2025
  1. Kayla Freeman Nurse Practitioner, Pediatrics · Springdale, AR $550 9% · 2 payments
  2. Michael Cruz Endocrinology, Diabetes & Metabolism · Chula Vista, CA $440 7% · 4 payments
  3. Kathleen Wyne Endocrinology, Diabetes & Metabolism · Columbus, OH $275 4% · 1 payment
  4. Crisostomo Armada Family Medicine · Rancho Cucamonga, CA $275 4% · 1 payment
  5. Ivette Cardona Ruelle General Practice · Tampa, FL $275 4% · 1 payment

The top 5 of 39 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $2,255 37% · 16 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $1,100 18% · 5 practitioners
  3. Nurse Practitioner, Pediatrics Nurse Practitioner $550 9% · 1 practitioner
  4. Pediatric Endocrinology Pediatrics $495 8% · 2 practitioners
  5. Nurse Practitioner $440 7% · 5 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $1,210 20% · 7 recipients
  2. Arkansas $1,045 17% · 3 recipients
  3. Florida $770 13% · 6 recipients
  4. Ohio $715 12% · 3 recipients
  5. New York $660 11% · 6 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

122 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record